CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

ONCOLOGY Nurse Edition. Vol. 22 No. 8
Pages: 1  2  3  4  5  
Next
 

Care of the Pregnant Patient With Cancer

By Sue Rimes, RN
Clinical Nurse, Outpatient

Jacalyn Gano, RN, OCN, MSW
Manager of Clinical Protocol Administration
Andrea Milbourne, MD
Associate Professor

Department of Gynecological Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

| July 1, 2008
An estimated 1 in 1,000 pregnancies is complicated by cancer, and the incidence of cancer during pregnancy is expected to increase as women delay childbirth until their later years. A diagnosis of cancer and the cancer treatment process can be particularly difficult for the pregnant patient, and are challenging for the physician and nurse. This article provides an overview of cancer treatment during pregnancy, discusses current practice guidelines and the oncology nursing role in caring for this unique patient population, and highlights resources for clinicians and patients.

A diagnosis of cancer and its subsequent treatment can be a very frightening and confusing experience for the pregnant patient, and are challenging for the physician and nurse. As women delay childbirth until later in life, the incidence of pregnancy associated with cancer is expected to increase. Currently, approximately 1 in 1,000 pregnancies is complicated by cancer.[1–5]

The tumors most commonly seen in women of childbearing age include cervical cancer, breast cancer, melanoma, lymphoma, and acute leukemia.[2–5] Today, many patients with these diagnoses choose to continue their pregnancies. Some patients may delay beginning treatment until after delivery, while others start treatment immediately. This decision depends on their diagnoses, stage of disease, and gestational age. Patients diagnosed late in their pregnancy may choose to deliver their babies early and then begin treatment immediately following delivery.

Patients treated while pregnant pose special challenges. When a cancer patient is pregnant, treatment decisions must take into account the welfare of the patient and the unborn baby. There is an obligation to do “good” for both mother and fetus.[1,6] This article provides an overview of cancer treatment during pregnancy and discusses current practice guidelines developed at our comprehensive cancer center, including the oncology nurse’s role in the care of these patients.
At our cancer center, to ensure continuity of care, a nurse from the Department of Gynecologic Oncology functions as a “nurse liaison” to assist our pregnant patients and their physicians. We have followed 89 pregnancies to date (4 women had 2 pregnancies since their cancer diagnosis). Figure 1 shows the distribution of disease types in a pregnant population at our cancer center between 2003 and April 2008. Figure 2 shows the outcome of pregnancies of patients who were
enrolled and followed in our data-collection study.

Anatomical and Physiological Changes During Pregnancy

Caring for a pregnant patient with cancer must take into account both anatomical and physiological changes occurring during pregnancy and risks associated with cancer diagnosis and treatment.
Maternal blood volume increases by about 40%–50% during pregnancy. Other hemodynamic changes include increases in cardiac output, systemic blood pressure, pulmonary vascular resistance, heart rate, and blood flow distribution. Coagulation properties change during pregnancy, resulting in an increased risk of pulmonary embolus and deep venous thrombosis.[7–9]

As the gravid uterus grows, anatomical changes occur. The diaphragm and abdominal organs are pushed upward. The heart changes in position, appearance, and function, and the heart rate increases and peaks in the third trimester. Respiratory and gastric functions may be altered.[7,8,10] Positioning the patient on her left side during the late stages of pregnancy ensures good circulation. When the mother is supine for long periods of time, the gravid uterus can compress the inferior vena cava and compromise circulation.[7–9]

Pregnancy Assessment in the Newly Diagnosed Patient

It is important to ask any female patient of childbearing age the date of her last menstrual period, before administering chemotherapy or performing any test with radiation. This provides an opportune moment to teach the patient the importance of contraception during cancer treatment. If pregnancy is suspected, but not certain, a serum pregnancy test should be done. In a normal pregnancy, the level of beta HCG (human chorionic gonadotropin) increases by 66% every 48 hours beginning at the time of implantation of the fertilized ovum. The first trimester is a period of organogenesis. Fetal exposure to chemotherapy agents in the first trimester may cause spontaneous abortion or congenital malformation.[2]

It is important to ask the patient about her desires for the pregnancy. If she is not certain and/or needs counseling, she may be referred to a gynecologist for consultation. The physician can review the impact of cancer treatment relative to gestational age and address questions or concerns. Some patients are quite clear as to what they want to do. For others, the decision is more difficult and more information is needed.


Figure 1: Cancer During Pregnancy—Distribution of disease types in the pregnant population at M.D. Anderson Cancer Center between 2003 and 2007. Data represent 89 pregnancies in 85 women.

As with any cancer patient, early diagnosis and treatment offer the best prognosis. Regardless of cancer stage at diagnosis, pregnant patients with cancer do not appear to have a more aggressive clinical course, and the biological behavior of the cancer appears not to be influenced by the pregnancy.[3] Outcomes are similar in pregnant vs nonpregnant women with cancer.[2]

Pages: 1  2  3  4  5  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





What are you thinking. . .
About this month’s articles/other issues in oncology? Contact: Anne.Landry@cmpmedica.com

 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
CME ACTIVITIES

Current Challenges in Metastatic Breast Cancer:

Patient Management and Treatment Strategies

Interactive Case Challenge Series

 

This series of case presentations (five individual cases) will provide oncologists and other healthcare professionals with strategies for evaluating evidence-based data on the latest treatments in metastatic breast cancer (MBC) and the application of that data into the development of individualized approaches to care, including overcoming resistance, in order to optimize management and outcomes for patients.

 

Go to Activity

 
CONNECT WITH US
Become a fan on
Facebook
Add us on
Google Plus
Follow us on
Twitter
Join us on
LinkedIn
Sign up for our
Newsletters
Subscribe to our
RSS Feed
CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy